Molecular Mechanism of Progesterone-Induced Antiproliferation in Rat Aortic Smooth Muscle Cells

The pathogenesis of atherosclerosis: a perspective for the 1990s

1993 • 10,730 citations

Principles of CDK regulation

1995 • 3,267 citations

Inhibitors of mammalian G1 cyclin-dependent kinases.

1995 • 3,258 citations

Cyclins and cancer II: Cyclin D and CDK inhibitors come of age

1994 • 2,122 citations

Mammalian G1 cyclins

1993 • 1,990 citations

Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence

1991 • 1,603 citations

Physiological Action of Progesterone in Target Tissues*

1997 • 912 citations

The Pathogenesis of Atherosclerosis: Atherogenesis and Inflammation

1989 • 701 citations

Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.

1991 • 669 citations

Progestin Regulation of Cellular Proliferation*

1990 • 659 citations

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone.

1990 • 603 citations

Developmental mechanisms underlying pathology of arteries

1990 • 445 citations

The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women

1995 • 423 citations

Progesterone Regulates Transcription of the p21 Cyclindependent Kinase Inhibitor Gene through Sp1 and CBP/p300

1998 • 352 citations

Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.

1993 • 295 citations

Cyclin dependent kinase regulation

1995 • 286 citations

Biphasic Regulation of Breast Cancer Cell Growth by Progesterone: Role of the Cyclin-Dependent Kinase Inhibitors, p21 and p27Kip1

1997 • 271 citations

Estrogen inhibits the response-to-injury in a mouse carotid artery model.

1995 • 252 citations

Progestins Both Stimulate and Inhibit Breast Cancer Cell Cycle Progression while Increasing Expression of Transforming Growth Factor α, Epidermal Growth Factor Receptor, c-fos, and c-myc Genes

1991 • 218 citations

The Molecular Biology of RU486. Is There a Role for Antiprogestins in the Treatment of Breast Cancer?*

1992 • 212 citations

Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.

1991 • 204 citations

Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

1991 • 172 citations

Progesterone Inhibits Estrogen-Induced Cyclin D1 and cdk4 Nuclear Translocation, Cyclin E- and Cyclin A-cdk2 Kinase Activation, and Cell Proliferation in Uterine Epithelial Cells in Mice

1999 • 169 citations

Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques.

1995 • 152 citations

Mechanisms of Cyclin-Dependent Kinase Inactivation by Progestins

1998 • 126 citations

Progesterone inhibits arterial smooth muscle cell proliferation

1997 • 123 citations

Estradiol inhibition of arterial neointimal hyperplasia after balloon injury

1994 • 117 citations

Magnolol suppresses proliferation of cultured human colon and liver cancer cells by inhibiting DNA synthesis and activating apoptosis

2002 • 96 citations

Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells

2001 • 74 citations

Cooperation of p27^Kip1 and p18^INK4c in Progestin-Mediated Cell Cycle Arrest in T-47D Breast Cancer Cells

2000 • 69 citations

ARE GONADAL HORMONES (ESTROGENS AND ANDROGENS) OF SIGNIFICANCE IN THE DEVELOPMENT OF ISCHEMIC HEART DISEASE?*

1968 • 65 citations

Influence of estrogens on lipoproteins in atherosclerosis.

1952 • 64 citations

The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer?

1992 • 51 citations

Involvement of both extracellular signal‐regulated kinase and c‐jun N‐terminal kinase pathways in the 12‐O‐tetradecanoylphorbol‐13‐acetate–induced upregulation of p21^Cip1 in colon cancer cells

2002 • 37 citations